Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America-Reference-Cited by-同舟云学术

Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

Published:2010-03-01 Issue:5 Volume:116 Page:1272-1280
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Stadler Walter M.,Figlin Robert A.,McDermott David F.,Dutcher Janice P.,Knox Jennifer J.,Miller Wilson H.,Hainsworth John D.,Henderson Charles A.,George Jeffrey R.,Hajdenberg Julio,Kindwall-Keller Tamila L.,Ernstoff Marc S.,Drabkin Harry A.,Curti Brendan D.,Chu Luis,Ryan Christopher W.,Hotte Sebastien J.,Xia Chenghua,Cupit Lisa,Bukowski Ronald M.,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2007

2. Recent progress in the management of advanced renal cell carcinoma;Garcia;CA Cancer J Clin,2007

3. Renal-cell carcinoma;Motzer;N Engl J Med,1996

4. Cytotoxic chemotherapy for advanced renal cell carcinoma;Yagoda;Urol Clin North Am,1993

5. Advanced renal cell carcinoma: current and emerging management strategies;Escudier;Drugs,2007

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Papillary Renal Cell Carcinoma: Current Evidence and Future Directions;Kidney Cancer;2024-05-07

2. Research Progress on Mechanism and Management of Adverse Drug Reactions of Anlotinib;Drug Design, Development and Therapy;2023-11

3. Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma;Biomedicines;2023-01-11

4. Therapeutic Options in Metastatic Renal Cancer;Hellenic Urology;2022-10

5. Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma—Future or the Past?;Cancers;2022-08-03